Risk Factors Associated with Endometrial Pathology in Premenopausal Breast Cancer Patients Treated with Tamoxifen.
CONCLUSION: In premenopausal BC patients treated with tamoxifen, abnormal uterine bleeding, increased endometrial thickness, and chemotherapy for BC were associated with the occurrence of endometrial cancer. These findings may provide useful information for gynecologic surveillance and counseling during tamoxifen treatment in premenopausal BC patients.
PMID: 32233174 [PubMed - in process]
Source: Yonsei Medical Journal - Category: Universities & Medical Training Authors: Lee M, Piao J, Jeon MJ Tags: Yonsei Med J Source Type: research
More News: Bleeding | Breast Cancer | Cancer | Cancer & Oncology | Cancer of the Uterus | Chemotherapy | Endometrial Biopsy | Endometrial Cancer | Hysteroscopy | Pathology | Polyps | Tamoxifen | Universities & Medical Training | Women